Literature DB >> 8544782

Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique.

O Hother-Nielsen1, J E Henriksen, J J Holst, H Beck-Nielsen.   

Abstract

The conventional isotope dilution technique was compared with the more accurate constant specific activity (SA) method at six different insulin levels. Paired euglycemic clamp studies were performed in 30 normal subjects (4-hour insulin infusion: 5, 10, 20, 40, 80, and 160 mU . m-2 . min-1) using primed-constant 3-3H-glucose infusion and either conventional unlabeled glucose infusates (Cold-GINF) or labeled glucose infusates (Hot-GINF) to maintain constant SA. At all insulin levels, both glucose disappearance (Rd) and hepatic glucose production (HGP) were underestimated by the conventional technique, and errors during the first 2 hours correlated with glucose infusion rates (GIRs) (r = .93, P < .00001). During the second hour, mean underestimation of HGP varied from 20% +/- 9% to 84% +/- 16% of basal rates from low-dose to high-dose insulin infusion studies. During prolonged equilibration (3 to 4 hours), errors decreased but were still significant in the two low-dose insulin infusion protocols during the fourth hour. In conclusion, using the conventional isotope dilution technique, suppression of glucose production was overestimated and stimulation of glucose Rd was underestimated, and these errors were greater the higher the GIR. Thus, artifactually greater hepatic and smaller peripheral effects may have been assumed for factors or therapies that influence insulin sensitivity in previous studies using a conventional isotope dilution technique, and therefore, reevaluation of these issues may be relevant in future studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8544782     DOI: 10.1016/s0026-0495(96)90204-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

Authors:  T Utriainen; P Nuutila; T Takala; P Vicini; U Ruotsalainen; T Rönnemaa; T Tolvanen; M Raitakari; M Haaparanta; O Kirvelä; C Cobelli; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.

Authors:  Mette Marie H Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore B Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Diabetologia       Date:  2015-08-14       Impact factor: 10.122

3.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Authors:  J Giebelstein; G Poschmann; K Højlund; W Schechinger; J W Dietrich; K Levin; H Beck-Nielsen; K Podwojski; K Stühler; H E Meyer; H H Klein
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

4.  Testosterone therapy increased muscle mass and lipid oxidation in aging men.

Authors:  Louise Frederiksen; Kurt Højlund; David M Hougaard; Kim Brixen; Marianne Andersen
Journal:  Age (Dordr)       Date:  2011-02-24

5.  Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study.

Authors:  A M Arafat; M Möhlig; M O Weickert; C Schöfl; J Spranger; A F H Pfeiffer
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

6.  Reduced plasma adiponectin concentrations may contribute to impaired insulin activation of glycogen synthase in skeletal muscle of patients with type 2 diabetes.

Authors:  K Højlund; J Frystyk; K Levin; A Flyvbjerg; J F P Wojtaszewski; H Beck-Nielsen
Journal:  Diabetologia       Date:  2006-04-12       Impact factor: 10.122

7.  Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.

Authors:  B F Vind; J B Birk; S G Vienberg; B Andersen; H Beck-Nielsen; J F P Wojtaszewski; K Højlund
Journal:  Diabetologia       Date:  2012-02-10       Impact factor: 10.122

8.  Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Authors:  Duc Son N T Le; Thomas Brookshire; Jonathan Krakoff; Joy C Bunt
Journal:  Metabolism       Date:  2009-03       Impact factor: 8.694

9.  The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

Authors:  J Koska; E Ortega; J C Bunt; A Gasser; J Impson; R L Hanson; J Forbes; B de Courten; J Krakoff
Journal:  Diabetologia       Date:  2008-12-23       Impact factor: 10.122

10.  Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner.

Authors:  Juraj Koska; Norbert Stefan; Susanne B Votruba; Steven R Smith; Jonathan Krakoff; Joy C Bunt
Journal:  Obesity (Silver Spring)       Date:  2008-09       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.